Physical Address
304 North Cardinal St.
Dorchester Center, MA 02124
FDA Approves Fifth Ustekinumab Biosimilar
The US Food and Drug Administration (FDA) has approved ustekinumab-srlf (Imuldosa) as a biosimilar to ustekinumab (Stelara) for the treatment of multiple inflammatory conditions. This is the fifth ustekinumab biosimilar approved by the FDA, and it is expected to become…
English